Halberd Corporation
OTC: HALB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- William A. Hartman
- Employees
- 3
- Headquarters
- Jackson Center, United States
- IPO year
- 2012
- Market cap
- $464.3K
- Website
- https://halberdcorporation.com
Loading HALB…
Loading profile data…Frequently asked questions about HALB
What does Halberd Corporation (HALB) do?
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of canc...
Where does HALB trade?
Halberd Corporation (HALB) trades on the Other OTC.
What sector is HALB in?
Halberd Corporation (HALB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Halberd Corporation?
William A. Hartman is the chief executive officer of Halberd Corporation (HALB).
Where is Halberd Corporation headquartered?
Halberd Corporation is headquartered in United States.
Does HALB pay a dividend?
Halberd Corporation (HALB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HALB go public?
Halberd Corporation (HALB) completed its initial public offering in 2012.